Status:
COMPLETED
Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Obesity
Binge Eating
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This controlled study will test the effectiveness of a stepped-care approach to a standard behavioral weight loss treatment for obese patients with Binge Eating Disorder (BED). The major question is w...
Detailed Description
The stepped-care arm of this study included an obesity medication intervention. At the start of the study, the active medication was sibutramine and was compared to a placebo control. On 10/8/2010, Ab...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Obese (BMI\>=30)
- Exclusion criteria:
- Medication regimen that represents medical contraindication to sibutramine
- Serious unstable or uncontrolled medical conditions that represent contraindication to sibutramine
- Pregnancy
Exclusion
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
191 Patients enrolled
Trial Details
Trial ID
NCT00829283
Start Date
November 1 2008
End Date
November 1 2013
Last Update
April 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale School of Medicine
New Haven, Connecticut, United States, 06520